Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2016
Total Assets: $6.97B
Liabilities Breakdown FY2016
Total Liabilities: $2.52B
Asset Breakdown
Total Assets: $6.97B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $535.2M | 7.7% |
| Accounts Receivable | $1.34B | 19.3% |
| Inventory | $399.4M | 5.7% |
| Property, Plant & Equipment | $2.08B | 29.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.61B | 37.5% |
Liabilities Breakdown
Total Liabilities: $2.52B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $135.0M | 5.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.39B | 94.7% |